Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

Z. Li, A. Rakkar, Y. Katayose, M. Kim, N. Shanmugam, S. Srivastava, J. W. Moul, D. G. McLeod, K. H. Cowan, P. Seth

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Infection of Renca cells in vitro with a recombinant adenovirus expressing a marker gene β-galactosidase resulted in high level of the transgene expression. Renca tumors grown in Balb/C mice were also infectable with this recombinant adenovirus. The transgene expression in the tumors lasted for about 7 days, however, administration of another of Ad-βgal, on day 7 produced β-galactosidase expression. To investigate the effect of antibodies to adenovirus, animals were injected with multiple doses of adenovirus to produce neutralizing antibodies. To these animals Renca cells were injected and tumors formed. Interestingly, when Adβ-gal was administered into these tumors, a high level of transgene expression was still observed. We next explored the utility of a recombinant adenovirus expressing p53 (AdWTp53) in the Renca tumor model. Renca cells when exposed to an adenovirus expressing p53 (AdWTp53) produced a high level of p53 protein, a p53-inducible gene p21/WAF1/Cip1 and underwent apoptosis. A single injection of AdWTp53 (109 plaque forming units) resulted in significant inhibition of tumor growth. However, multiple administrations (four doses of 2.5 x 108 plaque forming units) of AdWTp53 were needed for tumor cures. Mixing uninfected and AdWTp53-infected cells showed a bystander effect of AdWTp53-infected Renca cells. Based on these results we believe that an appropriate dose scheduling of AdWTp53 can be efficacious for cancer gene therapy in immune-competent tumor-bearing animals.

Original languageEnglish (US)
Pages (from-to)605-613
Number of pages9
JournalGene Therapy
Volume5
Issue number5
DOIs
StatePublished - Jan 1 1998

Fingerprint

Adenoviridae
Neoplasms
Transgenes
Galactosidases
Bystander Effect
Neoplasm Genes
p53 Genes
Neutralizing Antibodies
Genetic Therapy
Apoptosis
Injections
Antibodies
Growth
Infection
Genes
Proteins

Keywords

  • Adenovirus
  • Apoptosis
  • Bystander effect
  • Gene therapy
  • p53

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model. / Li, Z.; Rakkar, A.; Katayose, Y.; Kim, M.; Shanmugam, N.; Srivastava, S.; Moul, J. W.; McLeod, D. G.; Cowan, K. H.; Seth, P.

In: Gene Therapy, Vol. 5, No. 5, 01.01.1998, p. 605-613.

Research output: Contribution to journalArticle

Li, Z, Rakkar, A, Katayose, Y, Kim, M, Shanmugam, N, Srivastava, S, Moul, JW, McLeod, DG, Cowan, KH & Seth, P 1998, 'Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model', Gene Therapy, vol. 5, no. 5, pp. 605-613. https://doi.org/10.1038/sj.gt.3300636
Li, Z. ; Rakkar, A. ; Katayose, Y. ; Kim, M. ; Shanmugam, N. ; Srivastava, S. ; Moul, J. W. ; McLeod, D. G. ; Cowan, K. H. ; Seth, P. / Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model. In: Gene Therapy. 1998 ; Vol. 5, No. 5. pp. 605-613.
@article{b948454c37db47b68d42d59f0ad6ff9a,
title = "Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model",
abstract = "Infection of Renca cells in vitro with a recombinant adenovirus expressing a marker gene β-galactosidase resulted in high level of the transgene expression. Renca tumors grown in Balb/C mice were also infectable with this recombinant adenovirus. The transgene expression in the tumors lasted for about 7 days, however, administration of another of Ad-βgal, on day 7 produced β-galactosidase expression. To investigate the effect of antibodies to adenovirus, animals were injected with multiple doses of adenovirus to produce neutralizing antibodies. To these animals Renca cells were injected and tumors formed. Interestingly, when Adβ-gal was administered into these tumors, a high level of transgene expression was still observed. We next explored the utility of a recombinant adenovirus expressing p53 (AdWTp53) in the Renca tumor model. Renca cells when exposed to an adenovirus expressing p53 (AdWTp53) produced a high level of p53 protein, a p53-inducible gene p21/WAF1/Cip1 and underwent apoptosis. A single injection of AdWTp53 (109 plaque forming units) resulted in significant inhibition of tumor growth. However, multiple administrations (four doses of 2.5 x 108 plaque forming units) of AdWTp53 were needed for tumor cures. Mixing uninfected and AdWTp53-infected cells showed a bystander effect of AdWTp53-infected Renca cells. Based on these results we believe that an appropriate dose scheduling of AdWTp53 can be efficacious for cancer gene therapy in immune-competent tumor-bearing animals.",
keywords = "Adenovirus, Apoptosis, Bystander effect, Gene therapy, p53",
author = "Z. Li and A. Rakkar and Y. Katayose and M. Kim and N. Shanmugam and S. Srivastava and Moul, {J. W.} and McLeod, {D. G.} and Cowan, {K. H.} and P. Seth",
year = "1998",
month = "1",
day = "1",
doi = "10.1038/sj.gt.3300636",
language = "English (US)",
volume = "5",
pages = "605--613",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

AU - Li, Z.

AU - Rakkar, A.

AU - Katayose, Y.

AU - Kim, M.

AU - Shanmugam, N.

AU - Srivastava, S.

AU - Moul, J. W.

AU - McLeod, D. G.

AU - Cowan, K. H.

AU - Seth, P.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Infection of Renca cells in vitro with a recombinant adenovirus expressing a marker gene β-galactosidase resulted in high level of the transgene expression. Renca tumors grown in Balb/C mice were also infectable with this recombinant adenovirus. The transgene expression in the tumors lasted for about 7 days, however, administration of another of Ad-βgal, on day 7 produced β-galactosidase expression. To investigate the effect of antibodies to adenovirus, animals were injected with multiple doses of adenovirus to produce neutralizing antibodies. To these animals Renca cells were injected and tumors formed. Interestingly, when Adβ-gal was administered into these tumors, a high level of transgene expression was still observed. We next explored the utility of a recombinant adenovirus expressing p53 (AdWTp53) in the Renca tumor model. Renca cells when exposed to an adenovirus expressing p53 (AdWTp53) produced a high level of p53 protein, a p53-inducible gene p21/WAF1/Cip1 and underwent apoptosis. A single injection of AdWTp53 (109 plaque forming units) resulted in significant inhibition of tumor growth. However, multiple administrations (four doses of 2.5 x 108 plaque forming units) of AdWTp53 were needed for tumor cures. Mixing uninfected and AdWTp53-infected cells showed a bystander effect of AdWTp53-infected Renca cells. Based on these results we believe that an appropriate dose scheduling of AdWTp53 can be efficacious for cancer gene therapy in immune-competent tumor-bearing animals.

AB - Infection of Renca cells in vitro with a recombinant adenovirus expressing a marker gene β-galactosidase resulted in high level of the transgene expression. Renca tumors grown in Balb/C mice were also infectable with this recombinant adenovirus. The transgene expression in the tumors lasted for about 7 days, however, administration of another of Ad-βgal, on day 7 produced β-galactosidase expression. To investigate the effect of antibodies to adenovirus, animals were injected with multiple doses of adenovirus to produce neutralizing antibodies. To these animals Renca cells were injected and tumors formed. Interestingly, when Adβ-gal was administered into these tumors, a high level of transgene expression was still observed. We next explored the utility of a recombinant adenovirus expressing p53 (AdWTp53) in the Renca tumor model. Renca cells when exposed to an adenovirus expressing p53 (AdWTp53) produced a high level of p53 protein, a p53-inducible gene p21/WAF1/Cip1 and underwent apoptosis. A single injection of AdWTp53 (109 plaque forming units) resulted in significant inhibition of tumor growth. However, multiple administrations (four doses of 2.5 x 108 plaque forming units) of AdWTp53 were needed for tumor cures. Mixing uninfected and AdWTp53-infected cells showed a bystander effect of AdWTp53-infected Renca cells. Based on these results we believe that an appropriate dose scheduling of AdWTp53 can be efficacious for cancer gene therapy in immune-competent tumor-bearing animals.

KW - Adenovirus

KW - Apoptosis

KW - Bystander effect

KW - Gene therapy

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=7144257862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7144257862&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3300636

DO - 10.1038/sj.gt.3300636

M3 - Article

C2 - 9797864

AN - SCOPUS:7144257862

VL - 5

SP - 605

EP - 613

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 5

ER -